{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:14:04Z","timestamp":1793783644490,"version":"4.6.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ymgme.2023.107654","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T23:14:02Z","timestamp":1689203642000},"page":"107654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pilot study of newborn screening for six lysosomal diseases in Brazil"],"prefix":"10.1016","volume":"140","author":[{"given":"Francyne","family":"Kubaski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Brusius-Facchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.O.","family":"Netto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliano","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Vairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edina","family":"Poletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Trometer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Ranieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zackary M.","family":"Herbst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Gelb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2023.107654_bb0005","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymgme.2023.107654_bb0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-med-122313-085916","article-title":"Lysosomal storage diseases: from pathophysiology to therapy","volume":"66","author":"Parenti","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymgme.2023.107654_bb0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-neuro-070815-014031","article-title":"Brain disorders due to lysosomal dysfunction","volume":"39","author":"Fraldi","year":"2016","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ymgme.2023.107654_bb0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ddrr.1117","article-title":"Newborn screening for lysosomal storage disorders and other neuronopathic conditions","volume":"17","author":"Matern","year":"2013","journal-title":"Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.ymgme.2023.107654_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/ijns8040062","article-title":"Liquid chromatography\u2013tandem mass spectrometry in newborn screening laboratories","volume":"8","author":"Gelb","year":"2022","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2023.107654_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.559804","article-title":"CNS-targeting therapies for lysosomal storage diseases: current advances and challenges","volume":"7","author":"Edelmann","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymgme.2023.107654_bb0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajmg.c.30291","article-title":"Newborn screening for lysosomal storage disorders","volume":"157","author":"Nakamura","year":"2011","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.ymgme.2023.107654_bb0040","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ana.24246","article-title":"Early treatment is associated with improved cognition in Hurler syndrome","volume":"76","author":"Poe","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2023.107654_bb0045","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbamcr.2008.08.009","article-title":"Treating lysosomal storage disorders: current practice and future prospects","volume":"1793","author":"Platt","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2023.107654_bb0050","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012836","article-title":"The rapidly evolving view of lysosomal storage diseases","volume":"13","author":"Parenti","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymgme.2023.107654_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/ijns4030023","article-title":"Newborn screening for lysosomal storage diseases: methodologies, screen positive rates, normalization of datasets, second-tier tests, and post-analysis tools","volume":"4","author":"Gelb","year":"2018","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2023.107654_bb0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ymgme.2012.04.013","article-title":"Algorithm for Pompe disease newborn screening: results from the Taiwan screening program","volume":"106","author":"Chiang","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107654_bb0065","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1542\/peds.2009-1728","article-title":"Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up","volume":"125","author":"Gabrielli","year":"2010","journal-title":"Pediatrics."},{"key":"10.1016\/j.ymgme.2023.107654_bb0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12881-016-0284-4","article-title":"12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment","volume":"17","author":"Gabrielli","year":"2016","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ymgme.2023.107654_bb0075","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1182\/bloodadvances.2021006094","article-title":"Benefits of newborn screening and hematopoietic cell transplant in infantile Krabbe disease","volume":"6","author":"Page","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymgme.2023.107654_bb0080","author":"Newborn Screening Status for All Disorders | NewSTEPs"},{"key":"10.1016\/j.ymgme.2023.107654_bb0085","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpeds.2019.09.036","article-title":"Newborn screening for mucopolysaccharidoses: results of a pilot study with 100000 dried blood spots","volume":"216","author":"Scott","year":"2020","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107654_bb0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10545-017-0098-3","article-title":"Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy","volume":"41","author":"Burlina","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107654_bb0095","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.cca.2012.07.011","article-title":"First pilot newborn screening for four lysosomal storage diseases in an Italian region: identification and analysis of a putative causative mutation in the GBA gene","volume":"413","author":"Paciotti","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2023.107654_bb0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/ijns7010015","article-title":"Neonatal screening in Europe revisited: an ISNS perspective on the current state and developments since 2010","volume":"7","author":"Loeber","year":"2021","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2023.107654_bb0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0140-6736(11)61266-X","article-title":"Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria","volume":"379","author":"Mechtler","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2023.107654_bb0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jpeds.2018.09.063","article-title":"Taiwan National Newborn Screening Program by tandem mass spectrometry for mucopolysaccharidoses types I, II, and VI","volume":"205","author":"Chan","year":"2019","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107654_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-020-1322-z","article-title":"Newborn screening for Morquio disease and other lysosomal storage diseases: results from the 8-plex assay for 70,000 newborns","volume":"15","author":"Chien","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2023.107654_bb0120","article-title":"Newborn screening for Gaucher disease in Japan","volume":"31","author":"Sawada","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"8","key":"10.1016\/j.ymgme.2023.107654_bb0125","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/jhg.2013.48","article-title":"Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study","volume":"58","author":"Inoue","year":"2013","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2023.107654_bb0130","first-page":"6","article-title":"Levels of enzyme activities in six lysosomal storage diseases in Japanese neonates determined by liquid chromatography-tandem mass spectrometry","volume":"9","author":"Mashima","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2023.107654_bb0135","article-title":"Establishment of cutoff values for newborn screening of six lysosomal storage disorders by tandem mass spectrometry","volume":"10","author":"Li","year":"2022","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107654_bb0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2017.03.001","article-title":"Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: three-year findings from a screening program in a closed Mexican health system","volume":"121","author":"Navarrete-Mart\u00ednez","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107654_bb0145","series-title":"Newborn Screening for Lysosomal Storage Disorders in Belgium: The Importance of Sex- and Age-Dependent Reference Ranges","volume":"5","author":"Eyskens","year":"2017"},{"key":"10.1016\/j.ymgme.2023.107654_bb0150","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1542\/peds.2004-0583","article-title":"Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy","volume":"114","author":"Meikle","year":"2004","journal-title":"Pediatrics."},{"key":"10.1016\/j.ymgme.2023.107654_bb0155","first-page":"23","article-title":"Newborn screening for hunter disease: a small-scale feasibility study","volume":"14","author":"Ruijter","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2023.107654_bb0160","first-page":"117","article-title":"Newborn screening for lysosomal storage disorders in Hungary","volume":"6","author":"Wittmann","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2023.107654_bb0165","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ymgme.2016.05.015","article-title":"Pilot study of newborn screening for six lysosomal storage diseases using tandem mass spectrometry","volume":"118","author":"Elliott","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107654_bb0170","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jpeds.2013.01.031","article-title":"Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry","volume":"163","author":"Scott","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107654_bb0175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1373\/clinchem.2014.225771","article-title":"Newborn screening for lysosomal storage disorders","volume":"61","author":"Gelb","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2023.107654_bb0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/cclm-2016-0340","article-title":"Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS\/MS","volume":"55","author":"Polo","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ymgme.2023.107654_bb0185","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41436-018-0129-y","article-title":"The New York pilot newborn screening program for lysosomal storage diseases: report of the first 65,000 infants","volume":"21","author":"Wasserstein","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107654_bb0190","article-title":"Newborn screening for lysosomal storage disorders: methodologies for measurement of enzymatic activities in dried blood spots","volume":"5","author":"Gelb","year":"2019","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2023.107654_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11070446","article-title":"Experience with the urinary tetrasaccharide metabolite for Pompe disease in the diagnostic laboratory","volume":"11","author":"Saville","year":"2021","journal-title":"Metabolites."},{"key":"10.1016\/j.ymgme.2023.107654_bb0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijns5020024","article-title":"Implementation of second-tier tests in newborn screening for lysosomal disorders in north eastern Italy","volume":"5","author":"Burlina","year":"2019","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2023.107654_bb0205","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1515\/cclm-2018-1301","article-title":"Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study","volume":"57","author":"Polo","year":"2019","journal-title":"Clin. Chem. Lab. Med."},{"issue":"7","key":"10.1016\/j.ymgme.2023.107654_bb0210","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s41436-020-0790-9","article-title":"A highly multiplexed biochemical assay for analytes in dried blood spots: application to newborn screening and diagnosis of lysosomal storage disorders and other inborn errors of metabolism","volume":"22","author":"Hong","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107654_bb0215","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ymgme.2017.05.015","article-title":"Psychosine, a marker of Krabbe phenotype and treatment effect","volume":"121","author":"Escolar","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107654_bb0220","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-016-9981-6","article-title":"Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry","volume":"40","author":"Kubaski","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107654_bb0225","first-page":"443","article-title":"Coincidental finding of Fabry\u2019s disease in a patient with IgA nephropathy","volume":"3","author":"Kakita","year":"2010","journal-title":"NDT Plus"},{"key":"10.1016\/j.ymgme.2023.107654_bb0230","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s12471-019-1250-5","article-title":"Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance","volume":"27","author":"van Lint","year":"2019","journal-title":"Neth. Hear. J."},{"key":"10.1016\/j.ymgme.2023.107654_bb0235","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s10038-019-0599-z","article-title":"Mutation spectrum of \u03b1-galactosidase gene in Japanese patients with Fabry disease","volume":"64","author":"Kobayashi","year":"2019","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2023.107654_bb0240","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1750-1172-8-182","article-title":"Phenotypical variation within 22 families with Pompe disease","volume":"8","author":"Wens","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2023.107654_bb0245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12881-014-0141-2","article-title":"Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G> C as the most common mutation","volume":"15","author":"Liu","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ymgme.2023.107654_bb0250","doi-asserted-by":"crossref","first-page":"32","DOI":"10.18043\/ncm.80.1.32","article-title":"What is newborn screening?","volume":"80","author":"Powell","year":"2019","journal-title":"NCMJ."},{"key":"10.1016\/j.ymgme.2023.107654_bb0255","first-page":"814","article-title":"Ten great public health achievements--worldwide, 2001-2010","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ymgme.2023.107654_bb0260","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ymgme.2011.09.017","article-title":"Genetic studies in a cluster of mucopolysaccharidosis type VI patients in Northeast Brazil","volume":"104","author":"Costa-Motta","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107654_bb0265","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1590\/1678-4685-gmb-2017-0227","article-title":"Neonatal screening for four lysosomal storage diseases with a digital microfluidics platform: initial results in Brazil","volume":"41","author":"Camargo Neto","year":"2018","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.ymgme.2023.107654_bb0270","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2018-0334","article-title":"Newborn screening for lysosomal disorders in Brazil: a pilot study using customized fluorimetric assays","volume":"43","author":"Bender","year":"2020","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.ymgme.2023.107654_bb0275","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41436-020-0764-y","article-title":"The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease","volume":"22","author":"Guenzel","year":"2020","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107654_bb0280","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/gim.2018.31","article-title":"Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis","volume":"21","author":"Maruyama","year":"2018","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107654_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10030155","article-title":"Elevated LysoGb3 concentration in the neuronopathic forms of mucopolysaccharidoses","volume":"10","author":"Baydakova","year":"2020","journal-title":"Diagnostics."},{"key":"10.1016\/j.ymgme.2023.107654_bb0290","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/jmedgenet-2014-102872","article-title":"Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease","volume":"52","author":"Smid","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2023.107654_bb0295","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1651-2227.2005.tb02112.x","article-title":"Is globotriaosylceramide a useful biomarker in Fabry disease?","volume":"94","author":"Young","year":"2007","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2023.107654_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237358","article-title":"A rapid and simple UHPLC-MS\/MS method for quantification of plasma globotriaosylsphingosine (lyso-Gb3)","volume":"26","author":"Perrone","year":"2021","journal-title":"Molecules."},{"key":"10.1016\/j.ymgme.2023.107654_bb0305","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13023-014-0111-y","article-title":"Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A)","volume":"9","author":"Liu","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2023.107654_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijns8020028","article-title":"COVID-19 pandemic-related impacts on newborn screening public health surveillance","volume":"8","author":"Singh","year":"2022","journal-title":"Int. J. Neonatal Screen."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107654_bb0315","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007780","article-title":"Global impact of COVID-19 on newborn screening programmes","volume":"7","author":"Koracin","year":"2022","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.ymgme.2023.107654_bb0320","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/ijns8020023","article-title":"Improving recruitment for a newborn screening pilot study with adaptations in response to the COVID-19 pandemic","volume":"8","author":"Wynn","year":"2022","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2023.107654_bb0325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/ijns8010007","article-title":"Common challenges and identified solutions for state newborn screening programs during COVID-19 pandemic","volume":"8","author":"Simon","year":"2022","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2023.107654_bb0330","article-title":"Newborn screening for Pompe disease in Italy: long-term results and future challenges","volume":"33","author":"Gragnaniello","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2023.107654_bb0335","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/ijns6020032","article-title":"Second tier molecular genetic testing in newborn screening for Pompe disease: landscape and challenges","volume":"6","author":"Smith","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2023.107654_bb0340","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/ijns6020031","article-title":"Newborn screening for Pompe disease","volume":"6","author":"Sawada","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2023.107654_bb0345","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ijns6010009","article-title":"The first year experience of newborn screening for Pompe disease in California","volume":"6","author":"Tang","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2023.107654_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1001154","article-title":"Development of a clinically validated in vitro functional assay to assess pathogenicity of novel GAA variants in patients with Pompe disease identified via newborn screening","volume":"13","author":"Goomber","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2023.107654_bb0355","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/ijns8040059","article-title":"Parental depression and anxiety associated with newborn bloodspot screening for rare and variable-onset disorders","volume":"8","author":"Boychuk","year":"2022","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2023.107654_bb0360","author":"PL 5043\/2020 - Senado Federal"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:55:00Z","timestamp":1761090900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223002846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":72,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1096719223002846"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107654","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pilot study of newborn screening for six lysosomal diseases in Brazil","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107654"}}